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Abstract
Objective: The neuropathogenesis of postoperative delirium remains unknown.
Low cerebrospinal ﬂuid (CSF) b-amyloid protein (Ab) and high CSF Tau levels
are associated with Alzheimer’s disease. We, therefore, assessed whether lower
preoperative CSF Ab/Tau ratio was associated with higher incidence and greater
severity of postoperative delirium. Methods: One hundred and ﬁfty-three par-
ticipants (71  5 years, 53% men) who had total hip/knee replacement under
spinal anesthesia were enrolled. CSF was obtained during initiation of spinal
anesthesia. The incidence and severity of postoperative delirium were deter-
mined by Confusion Assessment Method (CAM) and Memorial Delirium
Assessment Scale (MDAS) on postoperative day 1 and 2. Ab40, Ab42, and Tau
levels in the CSF were measured by enzyme-linked immunosorbent assay. The
relationships among these variables were determined, adjusting for age and gen-
der. Results: Participants in the lowest quartile of preoperative CSF Ab40/Tau
and Ab42/Tau ratio had higher incidence (32% vs. 17%, P = 0.0482) and
greater symptom severity of postoperative delirium (Ab40/Tau ratio: 4 vs. 3,
P = 0.034; Ab42/Tau ratio: 4 vs. 3, P = 0.062, the median of the highest MDAS
score) as compared to the combination of the rest of the quartiles. The
preoperative CSF Ab40/Tau or Ab42/Tau ratio was inversely associated with
MDAS score (Ab40/Tau ratio: 0.12  0.05, P = 0.014, adj. 0.12  0.05,
P = 0.018; Ab42/Tau ratio: 0.65  0.26, P = 0.013, adj. 0.62  0.27,
P = 0.022). Interpretation: Lower CSF Ab/Tau ratio could be associated with
postoperative delirium, pending conﬁrmation of our preliminary results in fur-
ther studies. These ﬁndings suggest potential roles of Ab and/or Tau in postop-
erative delirium neuropathogenesis.
Introduction
Postoperative delirium
1 is one of the most common post-
operative complications in elderly patients.
2 It has been
shown that postoperative delirium has independent
adverse effects on short and long-term mortality and
morbidity, including poor functional recovery, postopera-
tive cognitive dysfunction, deterioration in quality of life,
and increased costs
3–6 (reviewed in refs. 7, 8). However,
at the present time, postoperative delirium is a clinical
phenomenon, and its neuropathogenesis remains
unknown. This gap in knowledge has become a barrier
that limits further studies, including the development of
potential interventions for postoperative delirium.
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319b-Amyloid protein (Ab), including Ab40 and Ab42, is
the key component of senile plaques in Alzheimer’s dis-
ease (AD) patients. Tau is the major protein component
of intraneuronal neuroﬁbrillary tangles. Both Ab and Tau
are hallmark features of AD neuropathogenesis (reviewed
in ref. 9).
Lower levels of cerebrospinal ﬂuid (CSF) Ab42 have
been found to be associated with higher brain amyloid
amounts,
10–13 and appear in AD patients as compared to
normal controls.
14,15 Higher levels of CSF Tau are associ-
ated with elevated brain Tau levels,
13,16 and with the pro-
gression of AD.
17–19 Therefore, higher CSF Tau to Ab42
ratio
20 or lower CSF Ab42 to Tau ratio
21 can distinguish
AD patients from healthy controls and predict the devel-
opment of AD (reviewed in ref. 22). In addition to Ab42,
Ab40 has been shown to induce neurotoxicity
23–25 and is
associated with cognitive dysfunction and dementia.
26–28
Moreover, we recently published a study that reported
that both CSF Ab40/Tau ratio and Ab42/Tau ratio were
associated with postoperative cognitive changes, although
each ratio was associated with changes in different cogni-
tive domains.
29 We, therefore, used the CSF Ab/Tau ratio,
not the mathematically different but scientiﬁcally equiva-
lent CSF Tau/Ab ratio, in the studies, and assessed
whether human CSF Ab40/Tau or Ab42/Tau ratio would
be associated with postoperative delirium.
Therefore, we performed a prospective investigation in
patients who had elective total hip/knee replacement
under spinal anesthesia to assess whether there were asso-
ciations between preoperative human CSF Ab40/Tau or
Ab42/Tau ratio and the incidence and severity of postop-
erative delirium. The current proof of concept study was
performed in 153 participants. The primary hypothesis in
this study was that lower preoperative CSF Ab42/Tau
ratio would be associated with greater severity of post
operative delirium. Our secondary hypotheses were that
preoperative CSF Ab40/Tau ratio would be also associated
with postoperative delirium severity, and that both CSF
Ab42/Tau ratio and Ab40/Tau ratio would be associated
with the incidence of postoperative delirium. We chose
the severity of postoperative delirium in the current
research because there have been no studies to determine
the association between the human CSF biomarkers and
the severity of postoperative delirium. Moreover, given
our anticipated relatively small sample size, using the con-
tinuous outcome of delirium severity maximizes statistical
power, which is appropriate for this hypothesis generating
study. The outcomes from this study mainly served to
establish a system and to generate a concept that Ab and/
or Tau might contribute to the neuropathogenesis of
postoperative delirium, which would promote more stud-
ies to further investigate the neuropathogenesis of post
operative delirium.
Methods
Study enrollment
The protocol was approved by the Institutional Review
Board of Partners Human Research Committee, Boston,
MA, United States of America. A total of 354 adults who
were scheduled to have elective total hip or knee replace-
ment surgery at the Massachusetts General Hospital were
asked to participate in this study (see Fig. 1, the ﬂow dia-
gram). The inclusion criteria included: (1) 63 years old or
older; (2) proﬁcient in English, and (3) candidates for
spinal anesthesia. Individuals who met these criteria were
further screened in an initial interview. After reviewing
participant medical records, individuals excluded from
participation were those identiﬁed as having: (1) past
medical history of neurological and psychiatric diseases
including AD, other forms of dementia, stroke, or psycho-
sis; (2) severe visual or hearing impairment; and (3)
unwillingness to comply with the protocol or procedures.
Consent was obtained by study coordinators in the
Pre-Admissions Testing Area at Massachusetts General
Hospital when the participants came to the hospital for
preoperative evaluation. A total of 244 participants were
enrolled in the study from September 2011 to May 2013,
though 91 were excluded due to dropping out preopera-
tively or changing their mind about spinal anesthesia,
bringing the total number of participants to 153. There
have been no major changes in the surgery or anesthesia
practice since the start of our studies in 2011. We calcu-
lated that a sample size of 150 participants would be sufﬁ-
cient to determine a correlation >0.20 between Ab/Tau
ratio and Memorial Delirium Assessment Scale (MDAS)
score (which measures the severity of delirium
30) with
80% power and 5% type I error. The power calculation
354 Patients were eligible for screening 
244 Were enrolled in the study 
91 Were excluded 
    53 No longer interested in participating 
    31 No samples generated (general   
    anesthesia, surgery cancelled, etc.) 
    7 Other 
153 Were included in the analysis 
110 Declined to participate 
Figure 1. Flow diagram. The ﬂow diagram shows that 354
participants were initially screened for the studies and ﬁnally 153
participants were included in the data analysis.
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based on our primary hypothesis that lower preoperative
Ab42/Tau ratio was associated with greater severity of
postoperative delirium. We powered our study to be able
to detect a correlation of greater than 0.20 based on the
best estimation from our previous studies examining the
association between the preoperative CSF Ab40/Tau ratio
with the postoperative Brief Visuospatial Memory Test
Total Recall score, and between the preoperative CSF
Ab42/Tau ratio with the postoperative Hopkins Verbal
Learning Test Retention score.
29
Anesthesia, CSF sample collection, and
measurement of b-Amyloid and Tau
All of the participants had spinal anesthesia for the sched-
uled surgery. One milliliter of CSF was collected from a
spinal needle by anesthesiologists during the spinal anes-
thesia before the administration of the local anesthetic.
The CSF was collected in an Eppendorf tube and was
immediately placed in ice. The CSF was then stored in a
80°C degree freezer until the time of measurement
when the samples were thawed. Levels of Ab (including
Ab40 and Ab42) and total Tau in the CSF were measured
by using Enzyme-linked immunosorbent assay (ELISA)
kits (Ab40: Cat. # 292-62301; Ab42: Cat. # 296-64401,
Wako, Richmond, VA; Tau: Cat. # KHB0041, Invitrogen,
San Francisco, CA) as described in our previous studies.
29
The assay to measure the CSF Ab level was performed in
triplicate. The assay to measure the levels of CSF Tau was
performed in duplicate because we did not have a sufﬁ-
cient volume of CSF. The average level of CSF Ab40,
Ab42, and Tau was obtained and used for the data analy-
sis. All of the CSF samples in this study were analyzed
using the same methods by one person (Y. D.); therefore,
the relative differences in the values between the partici-
pants were consistent.
Surgery
All of the participants had total hip or total knee replace-
ment under spinal anesthesia by one surgeon to avoid
potential confounding factors owing to varying surgery
skills or different surgical practices. All of the participants
had standardized perioperative care, including spinal anes-
thesia, sedation, and postoperative pain control. The spinal
anesthesia included the administration of 0.5% bupivacaine
into the spinal space (mean dose: 3.24  0.63 mL). Most
patients received versed (midazolam, intravenous adminis-
tration, mean dose: 2.38  0.88 mg) before the surgery
and propofol (intravenous administration, mean dose:
279.89  162.1 mg) during the surgery for sedation. We
did not measure the depth of sedation in the current
studies. The postoperative pain control included a standard
postoperative pain management, for example, morphine
for patient-controlled analgesia (1 mg of morphine per
injection and the interval time of injection was 6 minutes
with a total of 10 mg of morphine per hour). There were
no major complications among the participants during the
immediate postoperative period.
Postoperative interviews
Trained clinical research assistants (C. S. and S. W.)
interviewed the patients on the ﬁrst and second day post
surgery. The assessment of delirium was performed once
per day between 8:00 AM to 10:00 AM. Patient notes were
not reviewed for episodes of delirium which could occur
outside the time of assessment. The clinical research
assistants who performed the delirium assessments in
this study had good training and went through quality
control procedures. We used state-of-the-art delirium
detection methods, which tend to report a higher inci-
dence of delirium. The interview included the Confusion
Assessment Method (CAM) and MDAS. CAM is a diag-
nostic algorithm used to determine the presence or
absence of delirium.
30,31 The CAM algorithm consists of
four clinical criteria: (1) acute onset and ﬂuctuating
course, (2) inattention, (3) disorganized thinking, and
(4) altered level of consciousness. For delirium to be
deﬁned, both the ﬁrst and the second criteria have to be
present, plus either the third and/or the fourth criterion.
MDAS was used to determine the severity of delir-
ium
30,32 by quantifying the symptoms related to delir-
ium based on 10 features, including reduced level of
consciousness/awareness, disorientation, short-term
memory impairment, impaired digit span, reduced abil-
ity to maintain and shift attention, disorganized think-
ing, perceptual disturbance, delusions, decreased or
increased psychomotor activity, and sleep–wake cycle
disturbance. Each of the features is scored from 0 (best)
to 3 (worst symptom) with a maximal score of 30 for
all of the features. Given that MDAS can evaluate the
features of delirium described in CAM and can be
administrated by trained nonclinical interviewers, we
chose to use the MDAS rather than the Delirium Rating
Scale (DRS).
33 The highest MDAS score from the post
operative day 1 and day 2 was presented in the studies.
MDAS scores were evaluated for all patients, regardless
of whether they met CAM criteria on that day.
Statistical analysis
The data were presented as median and interquartile
range (25–75% percentile) for Ab40/Tau or Ab42/Tau
ratio, and mean  standard deviation (SD) for other
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sented as a percentage. We used Mann–Whitney test to
determine the difference in Ab40/Tau or Ab42/Tau ratio
between the participants with and without postoperative
delirium. Chi-square test was used to compare the post-
operative delirium incidence between the participants in
the ﬁrst (lowest) quartile of Ab40/Tau or Ab42/Tau ratio
and the combination of the participants in the second,
third, and fourth (highest) quartile of Ab40/Tau or Ab42/
Tau ratio. Finally, we applied simple linear regression to
determine the association between the Ab40/Tau or
Ab42/Tau ratio and MDAS scores, and multiple linear
regression to determine the association after the adjust-
ment of age and gender. The regression coefﬁ-
cient  standard error (SE) was used to illustrate the
association between Ab40/Tau or Ab42/Tau ratio and
MDAS score. P-values less than 0.05 were considered sta-
tistically signiﬁcant. We used SAS (SAS institute Inc.,
Cary, NC) software (version 9.2) and Prism 6 software
(La Jolla, CA) to analyze the data.
Results
Characteristics of participants
Three hundred and ﬁfty-four eligible participants were
screened, among them 244 participants provided
informed consent for the study. Ninety-one participants
were subsequently excluded from the study owing to vari-
ous reasons (see Fig. 1, the ﬂow diagram), yielding 153
participants who were included in the ﬁnal data analysis.
The age, gender, and education of the 91 patients who
were excluded were comparable to those of the 153 par-
ticipants who were ﬁnally included in the data analysis.
The demographic and clinical data of the participants are
presented in Table 1. Thirty-one participants (20%) were
deﬁned as having postoperative delirium by using CAM.
The median of the highest MDAS score of all participants
(regardless of delirium status) over the ﬁrst two postoper-
ative days was 3 (2–5) (median and 25–75% percentile).
The median of the highest MDAS score of participants
with postoperative delirium was 7 (5–10), which was
higher than that of the participants without postoperative
delirium (3 [2–4] [P < 0.0001]). Because we have previ-
ously demonstrated that MDAS scores have prognostic
signiﬁcance even in patients without delirium,
30 we ana-
lyzed the MDAS scores in the entire population, not just
in those with delirium.
We did not include patients with dementia, stroke, or
psychosis in the studies because we believed we would
not be able to recruit enough participants with dementia,
stroke, or psychosis in the studies to determine the
contribution of these variables to postoperative cognitive
delirium. The primary goal of the current studies was to
assess a concept that Ab and/or Tau may contribute to
the neuropathogenesis of delirium, rather than validating
Ab and Tau as a biomarker for delirium. Therefore, pre-
operative cognitive function (e.g., Mini-Mental State
Table 1. Characteristics of the participants.
(N = 153)
Age (years)
Mean  SD 71  5
64–69 73 (48%)
70–75 43 (28%)
76–80 37 (24%)
Male sex – no. (%) 80 (52%)
Race or ethnic group, no. (%)
White 151 (98.7%)
Black 1 (0.65%)
Hispanic 0
Asian Indian 0
Others or unknown 1 (0.65%)
Education, no. (%)
Graduate of College or Postgraduate School 110 (72%)
Some College/Vocational/Technical Program 17 (11%)
High School Graduate/GED 19 (12%)
Less than high school graduation 4 (3%)
Unknown 3 (2%)
Height (cm) mean  SD 170  10
Body weight (kg) mean  SD 85  17
BMI (kg/m
2) mean  SD 29  5
ASA class
I1
II 119
III 27
Unknown 6
Length of anesthesia (min) 125  18
Length of surgery (min) 81  16
Total hip arthroplasty/replacement 72 (46%)
Total knee arthroplasty/replacement 83 (54%)
Estimated blood loss (mL) mean  SD 162  93
Ab40 (median and 25–75% percentile) 4820 (3800–6411)
pg/mL
Ab42 (median and 25–75% percentile) 570 (370–768)
pg/mL
Tau (median and 25–75% percentile) 380 (303–519)
pg/mL
Ab40/Tau ratio (median and 25–75% percentile) 12.6 (9.2–16.1)
Ab42/Tau ratio (median and 25–75% percentile) 1.4 (0.9–2.1)
The length of anesthesia was deﬁned from the time anesthesiologists
started the spinal anesthesia in the participants to the time when the
participants were sent to the post-anesthesia care unit. The length of
surgery was deﬁned from the time of initial incision to the time of the
closure of the skin. The values of Ab40, Ab42, Tau, Ab40/Tau ratio
and Ab42/Tau ratio in the CSF of all 153 participants were obtained
using ELISA methods (see text for details). ASA, American Society of
Anesthesiologists; GED, general educational development; cm, centi-
meter; min, minute; kg, kilogram; mL, milliliter, SD, standard devia-
tion; Ab, b-amyloid; CSF, cerebrospinal ﬂuid.
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studies.
The distribution of postoperative delirium
incidence in quartiles of preoperative CSF
Ab40/Tau or CSF Ab42/Tau ratio
The intra-assay coefﬁcient of variations of CSF Ab40,
Ab42, and Tau were 21.8%, 18.7%, and 6.8%, respec-
tively. The interparticipant coefﬁcient variations of CSF
Ab40, Ab42, and Tau were 35.5%, 45.7%, and 50.4%,
respectively. There was no signiﬁcant difference among
the values of CSF Ab40 (F = 0.028, P = 0.963, N.S., one-
way analysis of variance [ANOVA]), Ab42 (F = 1.600,
P = 0.215, N.S., one-way ANOVA), and Tau (P = 0.789,
N.S., Student’s t-test) obtained in different measurements.
The average ratio of preoperative CSF Ab40/Tau and
Ab42/Tau from the participants were 12.6 (9.2–16.1) and
1.4 (0.9–2.1) (median and 25–75% percentile), respec-
tively. We then compared these ratios in the participants
with postoperative delirium and those without it. Mann–
Whitney test showed that the preoperative CSF Ab40/Tau
(12.2 [8.1–14.8]) or Ab42/Tau ratio (1.3 [0.7–1.9]) in the
participants who developed postoperative delirium was
not signiﬁcantly different from those who did not develop
postoperative delirium (Ab40/Tau: 12.6 [9.6–16.1],
P = 0.241; or Ab42/Tau ratio: 1.4 [1.0–2.1], P = 0.192).
However, the relationship between preoperative CSF
Ab40/Tau or CSF Ab42/Tau ratio and postoperative delir-
ium incidence may not be linear (e.g., a threshold effect),
we, therefore, divided the participants into quartiles
according to the levels of preoperative CSF Ab40/Tau or
CSF Ab42/Tau ratio. We compared the incidence of post-
operative delirium among these quartiles and found that
more postoperative delirium occurred in the lowest quar-
tile of CSF Ab40/Tau (32%) or CSF Ab42/Tau ratio
(32%) than in the rest of three quartiles of the Ab40/Tau
ratio (second: 11%, third: 21% and fourth: 18%) or the
Ab42/Tau ratio (second: 8%, third: 24%, and fourth:
18%). Therefore, we dichotomized the preoperative Ab/
Tau ratio and compared the postoperative delirium inci-
dence between the participants in the ﬁrst quartile and
the participants in the combination of the second, third,
and fourth quartiles. We found a signiﬁcantly higher inci-
dence of delirium in participants with CSF Ab40/Tau
ratio in the lowest quartile versus all others (32% vs.
17%, P = 0.0482) and in participants with CSF Ab42/Tau
ratio in the lowest quartile versus all others (32% vs.
17%, P = 0.0482) (Fig. 2).
The distribution of postoperative delirium
severity in quartiles of preoperative CSF
Ab40/Tau or CSF Ab42/Tau ratio
Next, we asked whether the preoperative CSF Ab40/Tau
or CSF Ab42/Tau ratio could also be associated with the
postoperative delirium severity. We, therefore, compared
the MDAS score, the measurement of delirium severity,
between the participants in the ﬁrst quartile and the par-
ticipants in the combination of the second, third, and
fourth quartiles. We found that the median of the highest
MDAS score (4, 2–5) of the participants in the ﬁrst quar-
tile of CSF Ab40/Tau ratio was signiﬁcantly higher than
that of the participants in the combination of the second,
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Figure 2. The postoperative delirium incidence in the ﬁrst quartile and the combination of the other three quartiles of CSF Ab40/Tau or Ab42/
Tau ratio. Chi-square test shows that there is a signiﬁcant difference in the postoperative delirium incidence between the ﬁrst quartile (red bar)
and the combination of the second, third, and fourth quartiles (blue bar) of CSF Ab40/Tau (A) or Ab42/Tau ratio (B).
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P = 0.034, Fig. 3A). The median of the highest MDAS
score (4, 2–6) of the participants in the ﬁrst quartile of
CSF Ab42/Tau ratio were borderline higher than that of
the participants in the combination of the second, third,
and fourth quartiles of CSF Ab42/Tau ratio (3, 2–5,
P = 0.062, Fig. 3B).
Preoperative CSF Ab40/Tau or CSF Ab42/Tau
ratio and postoperative delirium severity
Finally, we determined the linear association between the
preoperative CSF Ab40/Tau or CSF Ab42/Tau ratio and
the MDAS score post surgery. Using an unadjusted
simple linear regression, we found that the preoperative
CSF Ab40/Tau or Ab42/Tau ratio was signiﬁcantly corre-
lated (negatively) with the highest MDAS score (Ab40/
Tau 0.12  0.05, P = 0.014; Ab42/Tau: 0.65  0.26,
P = 0.013) (Table 2). Thus, as CSF Ab/Tau goes down,
the MDAS scores go up, as would be expected given the
previous association of low CSF Ab40/Tau ratio with the
postoperative delirium incidence. Multiple linear regres-
sion, after adjusting for age and gender, showed that the
preoperative CSF Ab40/Tau (0.12  0.05, P = 0.018)
or Ab42/Tau (0.62  0.27, P = 0.022) ratio remained
signiﬁcantly correlated (negatively) with the highest
MDAS score (Table 2). Age did not contribute to the
association between Ab40/Tau ratio (P = 0.631) or Ab42/
Tau ratio (P = 0.757) and the highest MDAS score; gen-
der also did not contribute to the association between
Ab40/Tau ratio (P = 0.439) or Ab42/Tau ratio
(P = 0.679) and the highest MDAS score. We did not
include evaluation of other peri-operative variables (e.g.,
postoperative pain medication) in the analysis. As
opposed to age and gender, these postoperative variables
are highly complicated and require sophisticated adjust-
ment. For instance, nearly all patients are exposed to
postoperative opioids, therefore, meaningful adjustment
for postoperative pain medication requires consideration
of exposures to individual opioid agents, the dose of
exposure, and the time and duration of exposure. This
study was not sufﬁciently large enough to adjust for such
complex variables. We will take these factors into account
in future larger scale studies.
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Figure 3. The postoperative delirium severity in the ﬁrst quartile and the combination of the other three quartiles of CSF Ab40/Tau or Ab42/Tau
ratio. (A) Mann–Whitney test suggests that there is a signiﬁcant difference in the highest MDAS score between the ﬁrst quartile (red bar) and the
combination of the second, third, and fourth quartiles (blue bar) of CSF Ab40/Tau. (B) Mann–Whitney test suggests that there is a borderline
difference in the highest MDAS score between the ﬁrst quartile (red bar) and the combination of the second, third, and fourth quartiles (blue bar)
of CSF Ab42/Tau ratio.
Table 2. Correlation between MDAS score and the CSFAb40/Tau or Ab42/Tau ratio.
Highest MDAS score
Un-adjusted Adjusted by age and gender
Regression coefﬁcient  SE P Regression coefﬁcient  SE P
Ab40/Tau ratio 0.12  0.05 0.014 0.12  0.05 0.018
Ab42/Tau ratio 0.65  0.26 0.013 0.62  0.27 0.022
The left panel of the table illustrates the results of the regression coefﬁcients for CSF Ab40/Tau or Ab42/Tau ratio with highest MDAS score in a
simple linear regression. The right panel of the table shows the regression coefﬁcients in multiple linear regressions including adjustment of age
and gender. MDAS, Memorial Delirium Assessment Scale; CSF, cerebrospinal ﬂuid; SE, standard error.
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We assessed the association between preoperative CSF
Ab40/Tau or CSF Ab42/Tau ratio and the incidence and
severity of postoperative delirium in this prospective study
of 153 older adults who had total hip and knee replace-
ment under spinal anesthesia. Ab40, Ab42, and Tau have
been reported to contribute to neurotoxicity, cognitive
dysfunction, dementia, and postoperative cognitive
changes
14,15,17–19,23–29 (reviewed in ref. 9), and dementia is
a risk factor of delirium.
4,34 Therefore, we chose Ab40,
Ab42, and Tau in the studies to determine whether these
proteins may also contribute to postoperative delirium.
We found that the patients in the lowest quartile of
CSF Ab40/Tau and CSF Ab42/Tau ratios (consistent with
the AD biomarker) had the highest incidence of delirium
(Fig. 2) and more severe symptoms of delirium repre-
sented by higher MDAS scores (Fig. 3). We also found
that lower CSF Ab40/Tau and CSF Ab42/Tau ratios were
signiﬁcantly associated with greater postoperative delirium
severity represented by a higher MDAS score (Table 2).
Collectively, these ﬁndings suggest that Ab and Tau may
contribute to the neuropathogenesis of postoperative
delirium, pending further studies.
Delirium incidence is a dichotomous outcome; there-
fore, we did not use linear models to analyze the inci-
dence of postoperative delirium. Preoperative CSF Ab/
Tau ratio was not signiﬁcantly associated with the postop-
erative delirium incidence, but was associated with the
severity of postoperative delirium. We believe this differ-
ence is explained primarily by issues of statistical power.
It is notable that lower preoperative CSF Ab/Tau ratio is
associated with both higher incidence and greater symp-
tom severity of postoperative delirium, which is demon-
strated in Figures 2, 3, respectively.
The postoperative delirium incidence depends on type
of surgery, varying from 12% (otolaryngological surgery)
up to 50% (major abdominal surgery) (reviewed in ref.
7). The postoperative delirium incidence in the patients
who have total joint replacement has been reported to be
from 3.6% to 41%
35–39 (reviewed in ref. 40). The inci-
dence of postoperative delirium after total joint replace-
ment in all ages of patients is 9–15% (reviewed in ref.
40), and this incidence of postoperative delirium will be
higher in older adults. The variation in the postoperative
delirium incidence could be due to the inﬂuence of peri-
operative factors, including sedation levels,
41 cognitive
status, history of central nervous system disease, and post-
operative pain levels.
42 Therefore, the postoperative delir-
ium incidence (20%) in this study was consistent with
the incidence reported in other studies of total knee and
hip replacement, demonstrating validity to our delirium
assessment methods.
In a prospective cohort study in older adults with hip
fracture, Witlox et al. found that CSF Ab42, Tau, and
phosphorylated Tau were not associated with postopera-
tive delirium.
43 However, the studies by Witlox et al. did
not assess the association of preoperative CSF Ab/Tau
ratio with the postoperative delirium.
43 In the current
studies, we did not ﬁnd the association between preopera-
tive CSF Ab40, Ab42, or Tau with the incidence or sever-
ity of postoperative delirium either (data not shown).
However, we investigated the association between the pre-
operative CSF Ab40/Tau or Ab42/Tau ratio and the inci-
dence and severity of postoperative delirium, and we
found an inverse association. Also of note, the subject
population in the studies by Witlox et al. (patients who
had surgical repair for acute hip fracture) was different
from the participants in the current studies (patients who
had elective total hip or total knee replacement). Taken
together, the cohort and the variables measured were dif-
ferent between the studies by Witlox et al. and our cur-
rent studies, which might explain the different ﬁndings
and conclusions.
Lower levels of CSF Ab42 and higher levels of CSF Tau
are associated with the progression of AD.
14,15,17–19
Therefore, CSF Tau/Ab42 ratio has been used for the
diagnosis of AD dementia and prediction of its progress.
The higher the CSF Tau/Ab42 ratio
20 or the lower CSF
Ab42 to Tau ratio,
21 the worse the cognitive function in
AD patients (reviewed in ref. 22). Consistently, the cur-
rent ﬁndings showed that the lower preoperative CSF
Ab40/Tau or Ab42/Tau ratio might also predict postoper-
ative delirium and suggested that more severe postopera-
tive delirium symptoms may occur. Dementia is known
as the most consistent risk factor of delirium.
4,34 Taken
together, these ﬁndings suggest that some AD neuro-
pathogenesis, for example, accumulation of Ab in the
brain, could also be part of the neuropathogenesis of
postoperative delirium. The future studies to further test
this hypothesis are warranted.
Moreover, low CSF Ab level represents high brain Ab
amounts, owing to the sequestration of Ab into brain
amyloid plaques,
16,44 and CSF Tau levels represent brain
Tau levels.
16,44 Therefore, the ﬁndings that a lower CSF
Ab/Tau ratio is associated with higher incidence and
greater severity of postoperative delirium also suggest that
elevated brain Ab levels may be associated with postoper-
ative delirium. This hypothesis is supported by the fact
that age is a risk factor of delirium,
3 and aging is associ-
ated with elevated levels of Ab
45 in the brain. Further
studies are needed to test this hypothesis by determining
whether the amount of amyloid in the brain is associated
with the incidence and severity of postoperative delirium,
for example, by using positron emission tomographic
imaging (PET) for amyloid.
46
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Ab40/Tau or CSF Ab42/Tau ratio was associated with
certain domains of postoperative cognitive change,
29 and
this study showed that the preoperative CSF Ab40/Tau or
CSF Ab42/Tau ratio was associated with the incidence
and severity of postoperative delirium symptoms. These
results suggest that changes in the levels of Ab and Tau
in CSF and brain may be a common neuropathogenesis
underlying both postoperative delirium and postoperative
cognitive dysfunction. This hypothesis is further sup-
ported by the ﬁndings that postoperative delirium is asso-
ciated with a signiﬁcant decline in cognitive ability during
the ﬁrst year after cardiac surgery.
4 Collectively, these
results would promote further studies to determine the
potential association, neuropathologically and behavior-
ally, among postoperative delirium, postoperative cogni-
tive dysfunction, and dementia.
Postoperative delirium has been suggested to relate to
neuroinﬂammation.
47 However, although all patients may
have a surgery-induced increase in proinﬂammatory cyto-
kines in the blood that can enter the brain through the
blood brain barrier
48,49 to induce neuroinﬂammation, not
every patient develops postoperative delirium. Thus, it is
plausible that patients who develop postoperative delir-
ium have other changes in the brain that facilitate neuro-
inﬂammation. The ﬁndings from the current studies that
lower CSF Ab/Tau ratio is associated with higher inci-
dence and greater severity of postoperative delirium
symptoms suggest that Ab or Tau could be one of these
changes.
It has been reported that there are large variations in
the levels of CSF Ab and Tau between the different stud-
ies,
50 which could be caused by the differences in analyti-
cal procedures and the analytical kits. The values of Ab
and Tau in our current studies might also be different
from those of the other studies. However, the CSF Ab
and Tau levels in the current studies were measured using
the same methods by the same person, who had ample
experience with the assays (Y.D.). Therefore, although the
absolute values of CSF Ab and Tau may differ from those
reported in other studies, the relative differences in the
CSF Ab and Tau levels between the subjects are consis-
tent. Moreover, the intra-assay coefﬁcient of variations of
CSF Ab40 (21.8%), Ab42 (18.7%), and Tau (6.8%) were
still in the acceptable to good range, and within the range
reported elsewhere in the literature (13–36%).
50 Finally,
there was no signiﬁcant difference among the repeated
values of CSF Ab40, Ab42, and Tau obtained in different
measurements of our current studies. Taken together, we
believe the results provide strong evidence that the associ-
ations between the CSF Ab/Tau ratio and the postopera-
tive delirium incidence and severity in the current studies
are valid.
This study has several limitations. First, the majority of
the participants were white and had education beyond
high school. It remains unknown whether the association
between CSF Ab/Tau ratio and postoperative delirium
would still exist in nonwhite participants with lower edu-
cation levels. Second, we did not determine the preopera-
tive cognitive function (e.g., MMSE) in this study,
therefore, it remains unknown whether the relationship
between preoperative CSF Ab/Tau ratio and postoperative
delirium remains signiﬁcant after adjusting for measured
preoperative cognitive function. However, the primary
goal of the current studies was not to validate the CSF
Tau/Ab ratio as an independent predictive biomarker for
delirium, but rather to assess a concept that Ab and Tau
might contribute to the neuropathogenesis of delirium.
Therefore, we did not want to adjust for MMSE because
low preoperative cognitive function (measured by MMSE)
would be on the causal pathway between Ab and Tau
effects and delirium. However, given we did not perform
baseline cognitive function, we could have missed some
(milder) cases of dementia. Third, we did not assess
whether patients had preoperative delirium. However, the
patients all came to hospital by themselves for elective
surgery, and they were assessed, including mental func-
tion examination, by both nurses and anesthesiologists
before surgery. Therefore, the likelihood of participants
having preoperative delirium is low. Finally, the spectrum
of delirium was mild in this study as the MDAS score
was relatively low. The observation could be due to the
fact that the population of this study was relatively
healthy and, it is possible that MDAS scores might repre-
sent mild reversible cognitive impairment. Nevertheless,
our ﬁndings with delirium severity complement and
extend the ﬁndings with CAM-deﬁned postoperative
delirium.
In conclusion, we have found that the patients who
have lower preoperative CSF Ab40/Tau or Ab42/Tau
ratio, particularly those in the lowest quartile, are more
likely to develop postoperative delirium and have more
severe symptoms. These ﬁndings have established a sys-
tem and generated a concept for the future studies. If
conﬁrmed and extended in future studies, these ﬁndings
may shed light on the currently undeﬁned neuropatho-
genesis of postoperative delirium. These studies will hope-
fully promote the development of more targeted
interventions to prevent and treat postoperative delirium,
ultimately leading to safer surgery care and better postop-
erative outcomes for patients.
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